ES8403118A1 - Un procedimiento para la preparacion de derivados del acido ascorbico. - Google Patents
Un procedimiento para la preparacion de derivados del acido ascorbico.Info
- Publication number
- ES8403118A1 ES8403118A1 ES518968A ES518968A ES8403118A1 ES 8403118 A1 ES8403118 A1 ES 8403118A1 ES 518968 A ES518968 A ES 518968A ES 518968 A ES518968 A ES 518968A ES 8403118 A1 ES8403118 A1 ES 8403118A1
- Authority
- ES
- Spain
- Prior art keywords
- ascorbic acid
- related compounds
- alkyl
- formula
- acid ethers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33934482A | 1982-01-15 | 1982-01-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES518968A0 ES518968A0 (es) | 1984-03-01 |
| ES8403118A1 true ES8403118A1 (es) | 1984-03-01 |
Family
ID=23328588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES518968A Expired ES8403118A1 (es) | 1982-01-15 | 1983-01-13 | Un procedimiento para la preparacion de derivados del acido ascorbico. |
| ES525239A Expired ES8502698A1 (es) | 1982-01-15 | 1983-08-30 | Un procedimiento para la preparacion de derivados del acido ascorbico |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES525239A Expired ES8502698A1 (es) | 1982-01-15 | 1983-08-30 | Un procedimiento para la preparacion de derivados del acido ascorbico |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0086554A1 (enFirst) |
| JP (1) | JPS58131978A (enFirst) |
| KR (1) | KR840003247A (enFirst) |
| AU (1) | AU1035183A (enFirst) |
| CA (1) | CA1181078A (enFirst) |
| DD (1) | DD209455A5 (enFirst) |
| DK (1) | DK14283A (enFirst) |
| ES (2) | ES8403118A1 (enFirst) |
| FI (1) | FI830078L (enFirst) |
| GB (1) | GB2114571A (enFirst) |
| GR (1) | GR77897B (enFirst) |
| IL (1) | IL67646A0 (enFirst) |
| PL (1) | PL240125A1 (enFirst) |
| PT (1) | PT76083B (enFirst) |
| RO (1) | RO86439B (enFirst) |
| ZA (1) | ZA83173B (enFirst) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552895A (en) * | 1983-03-14 | 1985-11-12 | Eli Lilly And Company | Furo[3,2-b]furan-2-(3H)-ones |
| JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| WO1986006720A1 (fr) * | 1985-05-17 | 1986-11-20 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, production desdits derives et preparation pharmaceutique pouvant en resulter |
| WO1986007592A1 (fr) * | 1985-06-18 | 1986-12-31 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, leur procede de preparation, et preparations les contenant |
| JPS60139619A (ja) * | 1983-12-27 | 1985-07-24 | Mutsuyuki Kochi | Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤 |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| ATE150750T1 (de) | 1988-09-01 | 1997-04-15 | Takeda Chemical Industries Ltd | Fumagillol-derivate |
| DE69024193T2 (de) * | 1989-09-11 | 1996-05-30 | Nippon Hypox Lab Inc | Ascorbinsäure-derivate |
| US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
| ATE125814T1 (de) * | 1990-03-07 | 1995-08-15 | Hoffmann La Roche | Verfahren zur herstellung von derivaten der ascorbinsäure. |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| JPH0429989A (ja) * | 1990-05-24 | 1992-01-31 | Nisshin Flour Milling Co Ltd | Ｌ―アスコルビン酸誘導体の製造法 |
| GB9026114D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | New compounds |
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| RU2126398C1 (ru) * | 1993-02-05 | 1999-02-20 | Плива, Фармацеутска, Кемийска, Прехрамбена и Козметичка Индустрия Дионичко Друштво Загреб | Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты |
| US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| EP1586322B1 (en) | 1996-11-05 | 2008-08-20 | The Children's Medical Center Corporation | Compositions comprising thalodimide and dexamethasone for the treatment of cancer& x9; |
| EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
| BR9909168A (pt) * | 1998-03-27 | 2000-12-05 | Lg Chemical Ltd | Derivados de ácido ascórbico polietoxilados como anti-oxidantes e processo para preparação dos mesmo |
| US6673828B1 (en) | 1998-05-11 | 2004-01-06 | Children's Medical Center Corporation | Analogs of 2-Phthalimidinoglutaric acid |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| AU2001230554A1 (en) * | 2000-02-01 | 2001-08-14 | Mutsuyuki Kochi | Neovascularization inhibitory compositions and method of inhibiting neovascularization |
| ATE298240T1 (de) * | 2000-03-31 | 2005-07-15 | Angiogene Pharm Ltd | Getrennte dosis therapien mit gefässschädigender aktivität |
| DE60118625T2 (de) * | 2001-07-26 | 2007-02-22 | Tagra Biotechnologies Ltd. | Stabilisierte ascorbinsäure -3- phosphat- derivate |
| KR100971599B1 (ko) | 2002-05-15 | 2010-07-20 | 비에이취엔 가부시끼가이샤 | 혈관 관련 질환의 예방 또는 치료를 위한 조성물 |
| EP1939192A1 (en) * | 2006-12-28 | 2008-07-02 | Neuropharma S.A. | Cyclopentanone derivatives, method of synthesis and uses thereof |
| FR2955493B1 (fr) * | 2010-01-28 | 2012-02-24 | Oreal | Utilisation de derives d'acide ascorbique en coloration des fibres keratiniques humaines, composition les comprenant, procede de coloration et dispositif |
| JP5602456B2 (ja) * | 2010-02-24 | 2014-10-08 | 日本精化株式会社 | アスコルビン酸誘導体 |
| WO2015048121A1 (en) * | 2013-09-25 | 2015-04-02 | University Of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
| US10105407B2 (en) * | 2015-06-09 | 2018-10-23 | John P. Crow, JR. | Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof |
| ES2843724T3 (es) | 2015-11-30 | 2021-07-20 | Inst Nat Sante Rech Med | Antagonistas de NMDAR para el tratamiento de la angiogénesis tumoral |
-
1983
- 1983-01-10 FI FI830078A patent/FI830078L/fi not_active Application Discontinuation
- 1983-01-10 IL IL67646A patent/IL67646A0/xx unknown
- 1983-01-10 RO RO109663A patent/RO86439B/ro unknown
- 1983-01-11 PT PT76083A patent/PT76083B/pt unknown
- 1983-01-11 ZA ZA83173A patent/ZA83173B/xx unknown
- 1983-01-11 CA CA000419220A patent/CA1181078A/en not_active Expired
- 1983-01-12 PL PL24012583A patent/PL240125A1/xx unknown
- 1983-01-12 DD DD83247195A patent/DD209455A5/de unknown
- 1983-01-13 GR GR70253A patent/GR77897B/el unknown
- 1983-01-13 JP JP58005144A patent/JPS58131978A/ja active Pending
- 1983-01-13 GB GB08300907A patent/GB2114571A/en not_active Withdrawn
- 1983-01-13 EP EP83300174A patent/EP0086554A1/en not_active Ceased
- 1983-01-13 ES ES518968A patent/ES8403118A1/es not_active Expired
- 1983-01-13 AU AU10351/83A patent/AU1035183A/en not_active Abandoned
- 1983-01-14 KR KR1019830000115A patent/KR840003247A/ko not_active Ceased
- 1983-01-14 DK DK14283A patent/DK14283A/da not_active Application Discontinuation
- 1983-08-30 ES ES525239A patent/ES8502698A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT76083B (en) | 1986-01-09 |
| AU1035183A (en) | 1983-07-21 |
| JPS58131978A (ja) | 1983-08-06 |
| DK14283D0 (da) | 1983-01-14 |
| FI830078A0 (fi) | 1983-01-10 |
| ES518968A0 (es) | 1984-03-01 |
| GR77897B (enFirst) | 1984-09-25 |
| FI830078A7 (fi) | 1983-07-16 |
| GB2114571A (en) | 1983-08-24 |
| RO86439A (ro) | 1985-03-15 |
| ES525239A0 (es) | 1985-01-16 |
| ZA83173B (en) | 1984-08-29 |
| PL240125A1 (en) | 1984-04-24 |
| PT76083A (en) | 1983-02-01 |
| FI830078L (fi) | 1983-07-16 |
| DD209455A5 (de) | 1984-05-09 |
| DK14283A (da) | 1983-07-16 |
| KR840003247A (ko) | 1984-08-20 |
| IL67646A0 (en) | 1983-05-15 |
| RO86439B (ro) | 1985-03-31 |
| GB8300907D0 (en) | 1983-02-16 |
| EP0086554A1 (en) | 1983-08-24 |
| ES8502698A1 (es) | 1985-01-16 |
| CA1181078A (en) | 1985-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8403118A1 (es) | Un procedimiento para la preparacion de derivados del acido ascorbico. | |
| KR840005718A (ko) | 오메프라졸 중간체의 제조방법 | |
| ES8503015A1 (es) | Una composicion de organopolisiloxano vulcanizable a la temperatura ambiente. | |
| ES2058257T5 (es) | Compuestos herbicidas. | |
| ES8402833A1 (es) | Procedimiento para la obtencion de azolilmetiloxiranos. | |
| FR2421171A1 (fr) | Procede de preparation de tetrahydrobenzoxocines et de cis-hexahydrodibenzopyranones | |
| ES8704943A1 (es) | Un procedimiento para la fabricacion de derivados de cefalosporina. | |
| FR2366273A1 (fr) | Procede de preparation de sels d'arylsulfonium | |
| ES8801284A1 (es) | Procedimiento para preparar nuevos compuestos de benzotiofeno y benzofurano | |
| ES8301978A1 (es) | Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles. | |
| ES8607299A1 (es) | Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas | |
| FR2366285A1 (fr) | (3-amino-5-substitue-6-fluoropyrazinoyl ou pyrazamido) guanidines et leurs derives portant des substituants sur les atomes d'azote du noyau de guanidine, utiles comme medicaments | |
| ES8301200A1 (es) | Procedimiento para la preparacion de derivados de ciclohexe-no | |
| FR2383185A1 (enFirst) | ||
| FR2405942A1 (fr) | Procede d'obtention du 3-oxa-tricyclo (6.2.1.02,7) undecane-4-one et son utilisation a titre d'agent parfumant | |
| FR2445318A1 (fr) | Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines | |
| ES8401064A1 (es) | Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos. | |
| ES8300332A1 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas | |
| JPS5626814A (en) | Antibacteria agent and its use | |
| ES8304952A1 (es) | Procedimiento para preparar derivados de alcanolamina. | |
| ES8705439A1 (es) | Procedimiento para preparar derivados de pirazol-(1,5-a)piridina | |
| FR2426688A1 (fr) | Nouvelles neplanocines antibiotiques | |
| ES8302647A1 (es) | Un procedimiento para la preparacion de guanidinas | |
| SE8201098L (sv) | Nya ergolinderivat, deras framstellning och farmaceutiska kompositioner derav | |
| SE8100074L (sv) | Forfarande for framstellning av ett furanderivat |